Nasopharyngeal swabs
Sponsors
Lebanese University, GlaxoSmithKline, Institut Curie, Assistance Publique - Hôpitaux de Paris, Osivax
Conditions
COVID-19/ Practical and safe diagnostic tools
COVID-19Covid19Infections, Respiratory TractInfluenzaRheumatoid ArthritisSpondyloarthritisVolunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection
Unknown Phase
A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom
TerminatedNCT01292213
Start: 2012-05-31End: 2013-02-28Updated: 2014-09-08
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
CompletedNCT04369066
Start: 2020-04-28End: 2022-05-13Updated: 2025-09-23
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
TerminatedNCT04584541
Start: 2020-06-11End: 2022-02-21Updated: 2026-03-30
Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19
Active, not recruitingLBCTR2021044780
Start: 2021-04-19Target: 90Updated: 2026-02-02
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
CompletedNCT06779981
Start: 2024-12-13End: 2025-06-19Updated: 2025-06-25